BioCentury
ARTICLE | Clinical News

Clinical chemistry reagents regulatory update

May 8, 2000 7:00 AM UTC

The FDA granted marketing clearance for nine HMGN clinical chemistry reagents for use in Cobas Mira, an analyzer developed by Roche Diagnostics Corp. (Indianapolis, Ind.) under the companies' Februar...